European Archives - Page 2 of 981 - European Medical Journal

Elevated NT-proBNP Linked to Higher Atrial Fibrillation Risk

NT-proBNP strongly predicts atrial fibrillation risk, particularly in older adults, with implications for improved risk stratification.

Thyroid Diseases Increase Cancer and Osteoporosis Risks in Sjögren’s Syndrome

Patients with primary Sjögren’s syndrome and thyroid diseases face heightened risks of malignancy and osteoporosis, linked to changes in immune cell activity, a new study reveals.

Oral Contraceptive Use Limited by Depression in Endometriosis

Mood lability and depression are significant factors contributing to oral contraceptive (OC) discontinuation in women with endometriosis…

Study Links Tumour Upstaging in Invasive Melanoma to Worse Outcomes

A recent study reveals that tumour upstaging in invasive melanoma occurs in 9.4% of cases and significantly worsens survival outcomes. Read more!

20 Dec 2024

Which Therapies Result in the Greatest Reductions in HbA1c and Body Weight?

A network meta-analysis of incretin-based therapies in patients with type 2 diabetes

RSV Vaccine Highly Effective for Older Adults

The RSVpreF vaccine provides robust protection for older adults against RSV-related hospitalisations and emergency department visits.

Early Surgery Outperforms Endoscopy in Chronic Pancreatitis Treatment

Patients with painful chronic pancreatitis and a dilated pancreatic duct benefit more from early surgery than an endoscopy-first approach.

Minoxidil to Treat Alopecia in Patients with Breast Cancer

Improvement or stability of alopecia was observed in all patients after 3–6 months of low-dose oral minoxidil use.

Achieving With Confidence In Patients with ALGS

KAYFANDA is now indicated for the treatment of cholestatic pruritus in patients with Alagille Syndrome (ALGS) aged 6 months or older…

Unravelling Prostate Cancer Treatments: Interview with Axel Heidenreich

EMJ is delighted to introduce Axel Heidenreich, Professor and Director at the University of Cologne, Germany, who spoke to us about…